SJMHS - LIVINGSTON — History
CCN 230069 | 3-year financial timeline | COVID resilience: 76/100
🛡️ Public data only — no PHI permitted on this instance.
$200M
Latest Revenue (FY2022)
+9.0%
Revenue CAGR (3yr)
15.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $169M | $201M | $200M | -0.5% | +9.0% |
| Operating Expenses | $157M | $169M | $170M | +0.8% | +4.1% |
| Operating Margin | 7.1% | 16.3% | 15.2% | -6.5% | +46.6% |
| Net Income | $12M | $33M | $31M | -6.9% | +59.8% |
| Licensed Beds | 42 | 42 | 42 | +0.0% | +0.0% |
| Total Patient Days | 10,459 | 11,611 | 11,649 | +0.3% | +5.5% |
| Medicare Day % | 33% | 36% | 36% | +0.7% | +4.8% |
| Medicaid Day % | 4% | 4% | 2% | -30.3% | -20.3% |
COVID Impact & Recovery
Resilience Score: 76/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +18.9% ($169M → $200M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+9.0%
This Hospital
+7.6%
State Avg
Latest Margin
15.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $216M | 19.3% |
| FY2024 (proj) | $232M | 23.4% |
| FY2025 (proj) | $248M | 27.5% |